RAMP2 / Receptor activity-modifying protein 2 · Western blot design guide

Design a Western Blot for RAMP2

Source-linked RAMP2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RAMP2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for RAMP2: expected band ~19.6 kDa, hero antibody A04768, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable RAMP2 Western blot protocol sheet — expected band ~19.6 kDa, antibody A04768, controls and PMC citations. Open the full RAMP2 WB guide →

RAMP2 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~19.6 kDa
Gel 15% (standard starting point)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated + Cleaved
Caveat Glycosylation-state controls
Gene-set association MSigDB C7 membership
Isoform 2 isoform(s)
Section 1

Source-Linked RAMP2 Western Blot Protocol Options

The A04768 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateextracts of various cell lines, (catalog A04768)
Gel %15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferShort semi-dry transfer; verify retention (standard starting point)
Membrane0.2 µm PVDF (standard starting point)
BlockingBlocking buffer: 3% nonfat dry milk in TBST (catalog A04768)
Primary antibodyA04768 · 1:1000 (catalog A04768)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodyGoat Anti-Rabbit IgG, 1:10000 (catalog A04768)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL (catalog A04768)
Section 2

What Is the Expected RAMP2 Western Blot Band Size?

RAMP2 has a predicted precursor mass of 19.6 kDa; signal-peptide cleavage, Asn130 glycosylation, and isoforms could affect migration, but no empirical band is supplied.

What am I looking at on my blot?
Band near 19.6 kDaconsistent with the predicted RAMP2 precursor mass; confirm identity with antibody controls
Band below 19.6 kDamay reflect removal of the signal peptide at residues 1–42
Band above 19.6 kDaN-linked glycosylation at Asn130 could affect migration, but a shift is not established
Multiple bandsisoforms 1 and 2 could contribute, but distinct migration is not established
💡Expected RAMP2 appearanceThe predicted RAMP2 precursor mass is 19.6 kDa; signal-peptide removal, Asn130 glycosylation, and isoforms could affect migration, but no empirical band size is supplied, so verify identity with ordinary controls.
How each factor affects band size
UniProt predicted massplaces the full-length precursor at 19.6 kDa
Signal peptide at residues 1–42cleavage could make mature RAMP2 smaller than the precursor
N-linked glycosylation at Asn130could increase apparent size; a visible shift is not established
Isoforms 1 and 2could differ in size; their masses and migration are not supplied
Why is my band missing or off?
SituationLikely causeNext action
No band in lysatemembrane RAMP2 may be poorly recovered or solubilizedcheck membrane extraction and use a positive-control lysate
Band higher than expectedAsn130 glycosylation could affect migrationcompare treated and untreated samples and confirm band identity
Band lower than expectedsignal-peptide cleavage could reduce sizecheck antibody epitope coverage and confirm band identity
Multiple bandsisoforms 1 and 2 are listed, but separate bands are unprovencompare isoform-specific expression or depletion controls
Weak or no signalmembrane protein recovery may be lowverify extraction, loading, and antibody performance with a positive control

Sample controls for RAMP2 Western blot

🧪For positive controls for RAMP2 in Western blot, you can use a verified RAMP2-positive sample; the supplied HPA data identify no tissue or cell line.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: RAMP2 is a membrane protein, and the missing HPA data prevent tissue-based control selection.

HPA tissue expression evidence for RAMP2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced RAMP2 Western Blot Tips

Deeper troubleshooting and optimisation questions for RAMP2, answered from its protein features.

How should RAMP2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could RAMP2 isoforms produce different bands?
Isoforms · Two isoforms are listed. At UniProt position 54, isoform 2 replaces E with EASVPT, adding five residues relative to isoform 1. The sequence difference may affect size, but the features do not show whether the isoforms resolve as separate bands.
Which glycosylation site matters for band assignment?
PTM · The supplied N-linked glycosylation site is Asn130 in UniProt numbering. Keep that coordinate convention when comparing papers or antibody information. A glycosylation annotation identifies a possible source of band variation; it does not establish the size or presence of a shifted band.
Does this guide establish induction of RAMP2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for RAMP2 Western blot?
Transfer · RAMP2 is a predicted 19.6-kDa, single-pass membrane protein. Choose transfer conditions that retain small proteins, and check transfer recovery when optimizing the blot. The supplied features do not specify a transfer method or settings.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A04768 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should RAMP2 bands be quantified across samples?
Quantitation · Quantify consistently assigned bands using matched sample preparation and detection conditions. Consider the two isoforms and the annotated Asn130 N-linked glycosylation site before combining bands. No empirical RAMP2 band position is supplied, so establish band identity before comparing amounts.
Why might a RAMP2 band differ from 19.6 kDa?
Interpretation · 19.6 kDa is the predicted mass for the 175-residue sequence. RAMP2 has a signal peptide at residues 1–42 and an N-linked glycosylation site at UniProt Asn130. Processing or glycosylation could affect apparent size, but these features alone do not establish a visible shift. No observed band size is supplied.

The annotated signal peptide spans UniProt residues 1–42. Account for possible signal-peptide removal when comparing a band with the predicted mass of the full sequence. The supplied features do not give a measured mass for processed RAMP2.

RAMP2 has two annotated disulfide bonds. Compare reducing and nonreducing samples under otherwise matched conditions if band behavior differs. The annotation alone does not predict a specific mobility change.

RAMP2 is annotated as a glycoprotein and forms heterodimers with CALCRL or CALCR. These features suggest possibilities to investigate, but a higher band alone cannot identify a glycosylated form or receptor complex. Compare reproducible bands across conditions and verify their RAMP2 identity.
Boster reagents

RAMP2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of extracts of various cell lines, using RAMP2 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit . Exposure time: 10s.
Anti-RAMP2 Antibody
Cat # A04768

The catalog reports A04768, an anti-RAMP2 antibody with reported Human, Mouse, and Rat reactivity. Its Western blot image uses extracts from various cell lines at 1:1000 dilution and 25 µg protein per lane; the caption does not identify the cell lines.

Which to pick: A04768 is the only listed option and has a Western blot image. Check its reported reactivity against your sample species; the image caption does not establish which species were tested.

Source: BosterBio RAMP2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.